药物诱导的青素症:强调文拉法辛作为潜在的罪祸首
Sujita Manandhar1, Arnija Rana1, Rabin Baniya1
1Department of Dermatology Nepal Medical College and Teaching Hospital Kathmandu Nepal.
Clinical case reports
|November 3, 2025
概括
文拉法辛是一种常见的抗抑郁药,可能很少引起青病,这是一种导致蓝色四肢的疾病. 这一案例凸显了认识到这种药物的副作用对于及时的患者护理的重要性.
科学领域:
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
- 临床病例报告 临床病例报告
背景情况:
- 青病是一种外周血管疾病,导致 extremities 的蓝色变色.
- 药物诱导的青病与SSRI和TCA有关,但文拉法辛不是以前报告的原因.
研究的目的:
- 报告一种可能由文拉法辛诱导的急性白病的新病例.
- 提高临床意识的文拉法辛作为一个可能的致病因子的青病.
主要方法:
- 一个40岁的女性患者的案例研究,呈现急性青斑症.
- 排除其他潜在原因,如雷诺现象和血管炎.
- 在停止服用文拉法辛后对症状的监测.
主要成果:
- 患者在开始服用文拉法辛后24小时内出现了急性青症.
- 实验室检测结果并不显著,其他差异性诊断被排除在外.
- 停止使用文拉法辛导致症状在一周内完全消失.
结论:
- 文拉法辛应该被认为是药物诱导的青病的潜在原因.
- 早期识别和管理拉法辛诱导的青病是预防并发症的关键.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...


